Mounjaro sales were $7.4 billion in the quarter, up 110%. Zepbound sales were $4.3 billion, up 123%. Verzenio sales were $1.6 ...

Samsung Biologics says its product carbon footprint (PCF) system has been validated by Det Norske Veritas (DNV).

Eisai Co. Ltd. and Shanghai Henlius Biotech Inc. have entered an exclusive commercialization and co-exclusive development and manufacturing license agreement for the anti-PD-1 antibody serplulimab in ...

The U.S. FDA has accepted and granted Priority Review for Pfizer’s supplemental Biologics License Application (sBLA) for HYMPAVZI.

AbbVie has submitted applications for a new indication for upadacitinib (RINVOQ) for the treatment of patients living with ...

4Q Loss: $1.6 billion (earnings were $411 million 4Q25) ...

Revenues up 7% in the quarter despite €801 million loss.

Braveheart Bio is naming Marc Evanchik Chief Scientific Officer (CSO) and appointing Brittany de Temple Senior Vice President ...

In 2026, some of the key industry trends essential to company success and maintaining stability include long-lasting ...

“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...

Charles River Laboratories will close its cell therapy contract development and manufacturing site in Hanover, Md., ...

OXB and Bristol Myers Squibb (BMS) are expanding a partnership regarding manufacture and supply of lentiviral vectors for BMS ...